Merck's Gardasil, billed as the first vaccine to prevent cervical cancer, is now just one step away from commercial approval after a unanimous vote in its favor by a federal advisory committee. Merck ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback